Susquehanna International Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

Susquehanna International Group’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,900	Closed	-$670K	–	13533
2024 Q1	$670K	Buy	+16,900	New	+$499K	﹤0.01%	7801

Susquehanna International Group's ALPN Position: Q2 2024 in Review

Susquehanna International Group sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 109,860 shares — an estimated $4.35M sold.

Susquehanna International Group first reported a position in ALPN in Q3 2015 and held it in 10 quarters. The position peaked at $4.35M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Susquehanna International Group reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Susquehanna International Group sold 109,860 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $4.35M.
Susquehanna International Group first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 10 quarters.
Susquehanna International Group's Alpine Immune Sciences Inc position peaked at $4.35M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.